vs
Side-by-side financial comparison of FEDERAL SIGNAL CORP (FSS) and Bio-Techne (TECH). Click either name above to swap in a different company.
FEDERAL SIGNAL CORP is the larger business by last-quarter revenue ($597.1M vs $311.4M, roughly 1.9× Bio-Techne). Bio-Techne runs the higher net margin — 16.4% vs 10.2%, a 6.2% gap on every dollar of revenue. On growth, FEDERAL SIGNAL CORP posted the faster year-over-year revenue change (26.5% vs -1.5%). Over the past eight quarters, FEDERAL SIGNAL CORP's revenue compounded faster (18.5% CAGR vs 1.3%).
The Federal Signal Company was an American manufacturer of railway signaling equipment in the early 20th century. It was located in Albany, New York.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
FSS vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $597.1M | $311.4M |
| Net Profit | $60.8M | $51.0M |
| Gross Margin | 28.4% | 66.9% |
| Operating Margin | 14.0% | 24.2% |
| Net Margin | 10.2% | 16.4% |
| Revenue YoY | 26.5% | -1.5% |
| Net Profit YoY | 21.6% | 126.0% |
| EPS (diluted) | $0.99 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $311.4M | ||
| Q4 25 | $597.1M | $295.9M | ||
| Q3 25 | $555.0M | — | ||
| Q2 25 | $564.6M | $317.0M | ||
| Q1 25 | $463.8M | $316.2M | ||
| Q4 24 | $472.0M | $297.0M | ||
| Q3 24 | $474.2M | $289.5M | ||
| Q2 24 | $490.4M | $306.1M |
| Q1 26 | — | $51.0M | ||
| Q4 25 | $60.8M | $38.0M | ||
| Q3 25 | $68.1M | — | ||
| Q2 25 | $71.4M | $-17.7M | ||
| Q1 25 | $46.3M | $22.6M | ||
| Q4 24 | $50.0M | $34.9M | ||
| Q3 24 | $53.9M | $33.6M | ||
| Q2 24 | $60.8M | $40.6M |
| Q1 26 | — | 66.9% | ||
| Q4 25 | 28.4% | 64.6% | ||
| Q3 25 | 29.1% | — | ||
| Q2 25 | 30.0% | 62.7% | ||
| Q1 25 | 28.2% | 67.9% | ||
| Q4 24 | 28.1% | 65.3% | ||
| Q3 24 | 29.6% | 63.2% | ||
| Q2 24 | 29.4% | 66.4% |
| Q1 26 | — | 24.2% | ||
| Q4 25 | 14.0% | 18.4% | ||
| Q3 25 | 16.9% | — | ||
| Q2 25 | 17.3% | -7.5% | ||
| Q1 25 | 14.2% | 12.2% | ||
| Q4 24 | 14.9% | 16.0% | ||
| Q3 24 | 16.0% | 13.8% | ||
| Q2 24 | 16.5% | 15.0% |
| Q1 26 | — | 16.4% | ||
| Q4 25 | 10.2% | 12.8% | ||
| Q3 25 | 12.3% | — | ||
| Q2 25 | 12.6% | -5.6% | ||
| Q1 25 | 10.0% | 7.1% | ||
| Q4 24 | 10.6% | 11.7% | ||
| Q3 24 | 11.4% | 11.6% | ||
| Q2 24 | 12.4% | 13.3% |
| Q1 26 | — | $0.32 | ||
| Q4 25 | $0.99 | $0.24 | ||
| Q3 25 | $1.11 | — | ||
| Q2 25 | $1.16 | $-0.11 | ||
| Q1 25 | $0.75 | $0.14 | ||
| Q4 24 | $0.80 | $0.22 | ||
| Q3 24 | $0.87 | $0.21 | ||
| Q2 24 | $0.99 | $0.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $63.7M | $209.8M |
| Total DebtLower is stronger | $564.6M | — |
| Stockholders' EquityBook value | $1.4B | $2.1B |
| Total Assets | $2.4B | $2.6B |
| Debt / EquityLower = less leverage | 0.41× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $209.8M | ||
| Q4 25 | $63.7M | $172.9M | ||
| Q3 25 | $54.4M | — | ||
| Q2 25 | $64.7M | $162.2M | ||
| Q1 25 | $57.5M | $140.7M | ||
| Q4 24 | $91.1M | $177.5M | ||
| Q3 24 | $73.7M | $187.5M | ||
| Q2 24 | $48.6M | $152.9M |
| Q1 26 | — | — | ||
| Q4 25 | $564.6M | $260.0M | ||
| Q3 25 | $201.2M | — | ||
| Q2 25 | $258.3M | $346.0M | ||
| Q1 25 | $266.9M | $330.0M | ||
| Q4 24 | $204.4M | $300.0M | ||
| Q3 24 | $223.3M | $300.0M | ||
| Q2 24 | $248.8M | $319.0M |
| Q1 26 | — | $2.1B | ||
| Q4 25 | $1.4B | $2.0B | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.3B | $1.9B | ||
| Q1 25 | $1.2B | $2.0B | ||
| Q4 24 | $1.2B | $2.1B | ||
| Q3 24 | $1.1B | $2.1B | ||
| Q2 24 | $1.1B | $2.1B |
| Q1 26 | — | $2.6B | ||
| Q4 25 | $2.4B | $2.5B | ||
| Q3 25 | $1.9B | — | ||
| Q2 25 | $1.9B | $2.6B | ||
| Q1 25 | $1.9B | $2.6B | ||
| Q4 24 | $1.8B | $2.7B | ||
| Q3 24 | $1.7B | $2.7B | ||
| Q2 24 | $1.7B | $2.7B |
| Q1 26 | — | — | ||
| Q4 25 | 0.41× | 0.13× | ||
| Q3 25 | 0.15× | — | ||
| Q2 25 | 0.20× | 0.18× | ||
| Q1 25 | 0.22× | 0.16× | ||
| Q4 24 | 0.17× | 0.14× | ||
| Q3 24 | 0.19× | 0.14× | ||
| Q2 24 | 0.23× | 0.15× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $97.2M | — |
| Free Cash FlowOCF − Capex | $89.5M | — |
| FCF MarginFCF / Revenue | 15.0% | — |
| Capex IntensityCapex / Revenue | 1.3% | — |
| Cash ConversionOCF / Net Profit | 1.60× | — |
| TTM Free Cash FlowTrailing 4 quarters | $227.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $97.2M | — | ||
| Q3 25 | $61.1M | — | ||
| Q2 25 | $59.7M | $98.2M | ||
| Q1 25 | $36.7M | $41.1M | ||
| Q4 24 | $90.6M | $84.3M | ||
| Q3 24 | $68.8M | $63.9M | ||
| Q2 24 | $40.6M | $75.5M |
| Q1 26 | — | — | ||
| Q4 25 | $89.5M | — | ||
| Q3 25 | $54.1M | — | ||
| Q2 25 | $52.4M | $93.3M | ||
| Q1 25 | $31.1M | $31.0M | ||
| Q4 24 | $82.1M | $77.5M | ||
| Q3 24 | $60.9M | $54.7M | ||
| Q2 24 | $24.8M | $57.5M |
| Q1 26 | — | — | ||
| Q4 25 | 15.0% | — | ||
| Q3 25 | 9.7% | — | ||
| Q2 25 | 9.3% | 29.4% | ||
| Q1 25 | 6.7% | 9.8% | ||
| Q4 24 | 17.4% | 26.1% | ||
| Q3 24 | 12.8% | 18.9% | ||
| Q2 24 | 5.1% | 18.8% |
| Q1 26 | — | — | ||
| Q4 25 | 1.3% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 1.3% | 1.5% | ||
| Q1 25 | 1.2% | 3.2% | ||
| Q4 24 | 1.8% | 2.3% | ||
| Q3 24 | 1.7% | 3.2% | ||
| Q2 24 | 3.2% | 5.9% |
| Q1 26 | — | — | ||
| Q4 25 | 1.60× | — | ||
| Q3 25 | 0.90× | — | ||
| Q2 25 | 0.84× | — | ||
| Q1 25 | 0.79× | 1.82× | ||
| Q4 24 | 1.81× | 2.42× | ||
| Q3 24 | 1.28× | 1.90× | ||
| Q2 24 | 0.67× | 1.86× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FSS
| Vehiclesandequipment | $403.4M | 68% |
| Parts | $66.8M | 11% |
| Publicsafetyandsecurityequipment | $62.2M | 10% |
| Rentalincome | $19.0M | 3% |
| Industrialsignalingequipment | $18.2M | 3% |
| Other | $14.9M | 2% |
| Warningsystems | $12.6M | 2% |
TECH
| Protein Sciences segment revenue | $226.2M | 73% |
| Diagnostics and Spatial Biology segment revenue | $85.6M | 27% |
| Other revenue (1) | $5.4M | 2% |
